×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
FDMT – 4d molecular therapeutics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
FDMT
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/18
08:07 am
fdmt
4D Molecular Therapeutics, Inc. (NASDAQ: FDMT) had its price target lowered by analysts at Bank of America Co. from $79.00 to $46.00. They now have a "buy" rating on the stock.
Medium
Report
4D Molecular Therapeutics, Inc. (NASDAQ: FDMT) had its price target lowered by analysts at Bank of America Co. from $79.00 to $46.00. They now have a "buy" rating on the stock.
12/16
08:07 am
fdmt
4DMT Announces Landmark Publication of 4D-150 Preclinical Data for the Treatment of Neovascular Retinopathies in IOVS [Yahoo! Finance]
Low
Report
4DMT Announces Landmark Publication of 4D-150 Preclinical Data for the Treatment of Neovascular Retinopathies in IOVS [Yahoo! Finance]
12/16
08:00 am
fdmt
4DMT Announces Landmark Publication of 4D-150 Preclinical Data for the Treatment of Neovascular Retinopathies in IOVS
Low
Report
4DMT Announces Landmark Publication of 4D-150 Preclinical Data for the Treatment of Neovascular Retinopathies in IOVS
11/26
07:01 am
fdmt
4D Molecular Therapeutics, Inc. (FDMT): An Oversold Healthcare Stock to Invest In Now [Yahoo! Finance]
Low
Report
4D Molecular Therapeutics, Inc. (FDMT): An Oversold Healthcare Stock to Invest In Now [Yahoo! Finance]
11/21
07:40 am
fdmt
4D Molecular Therapeutics, Inc. (NASDAQ: FDMT) is now covered by analysts at Morgan Stanley. They set an "underweight" rating and a $8.00 price target on the stock.
Medium
Report
4D Molecular Therapeutics, Inc. (NASDAQ: FDMT) is now covered by analysts at Morgan Stanley. They set an "underweight" rating and a $8.00 price target on the stock.
11/14
05:25 pm
fdmt
4D Molecular Therapeutics, Inc. (NASDAQ: FDMT) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $39.00 price target on the stock.
High
Report
4D Molecular Therapeutics, Inc. (NASDAQ: FDMT) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $39.00 price target on the stock.
11/14
01:34 pm
fdmt
4D Molecular Therapeutics, Inc. (NASDAQ: FDMT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $36.00 price target on the stock.
Low
Report
4D Molecular Therapeutics, Inc. (NASDAQ: FDMT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $36.00 price target on the stock.
11/14
12:07 pm
fdmt
4D Molecular Therapeutics, Inc. (NASDAQ: FDMT) had its price target lowered by analysts at Royal Bank of Canada from $40.00 to $39.00. They now have an "outperform" rating on the stock.
Low
Report
4D Molecular Therapeutics, Inc. (NASDAQ: FDMT) had its price target lowered by analysts at Royal Bank of Canada from $40.00 to $39.00. They now have an "outperform" rating on the stock.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/11
04:16 pm
fdmt
Form 8-K 4D Molecular Therapeutic For: Dec 06
Low
Report
Form 8-K 4D Molecular Therapeutic For: Dec 06
12/10
04:29 pm
fdmt
Form 4 4D Molecular Therapeutic For: Dec 09 Filed by: Kolchinsky Peter
Medium
Report
Form 4 4D Molecular Therapeutic For: Dec 09 Filed by: Kolchinsky Peter
12/6
04:29 pm
fdmt
Form SC 13G/A 4D Molecular Therapeutic Filed by: BlackRock, Inc.
Medium
Report
Form SC 13G/A 4D Molecular Therapeutic Filed by: BlackRock, Inc.
11/25
04:34 pm
fdmt
Form 3 4D Molecular Therapeutic For: Nov 13 Filed by: Kolchinsky Peter
Low
Report
Form 3 4D Molecular Therapeutic For: Nov 13 Filed by: Kolchinsky Peter
11/15
05:05 pm
fdmt
Form SC 13G/A 4D Molecular Therapeutic Filed by: RA CAPITAL MANAGEMENT, L.P.
Medium
Report
Form SC 13G/A 4D Molecular Therapeutic Filed by: RA CAPITAL MANAGEMENT, L.P.
11/14
05:46 pm
fdmt
Form SC 13G/A 4D Molecular Therapeutic Filed by: RA CAPITAL MANAGEMENT, L.P.
High
Report
Form SC 13G/A 4D Molecular Therapeutic Filed by: RA CAPITAL MANAGEMENT, L.P.
11/14
04:32 pm
fdmt
Form SC 13G/A 4D Molecular Therapeutic Filed by: VIKING GLOBAL INVESTORS LP
High
Report
Form SC 13G/A 4D Molecular Therapeutic Filed by: VIKING GLOBAL INVESTORS LP
11/14
03:15 pm
fdmt
Form SC 13G/A 4D Molecular Therapeutic Filed by: JANUS HENDERSON GROUP PLC
Low
Report
Form SC 13G/A 4D Molecular Therapeutic Filed by: JANUS HENDERSON GROUP PLC
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: